Overview

Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice

Status:
Completed
Trial end date:
2017-05-31
Target enrollment:
Participant gender:
Summary
This survey is conducted for preparing application material for re examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, and assessing the safety and efficacy profiles of VIVIANT in usual practice according to the Re-examination Regulation for New Drugs
Details
Lead Sponsor:
Pfizer
Treatments:
Bazedoxifene